BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28233676)

  • 1. Design, synthesis and preliminary biological evaluation of indole-3-carboxylic acid-based skeleton of Bcl-2/Mcl-1 dual inhibitors.
    Liu T; Wan Y; Liu R; Ma L; Li M; Fang H
    Bioorg Med Chem; 2017 Mar; 25(6):1939-1948. PubMed ID: 28233676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
    Xu G; Liu T; Zhou Y; Yang X; Fang H
    Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors.
    Wang Z; Xu W; Song T; Guo Z; Liu L; Fan Y; Wang A; Zhang Z
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27911011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of substituted tyrosine derivatives as Bcl-2/Mcl-1 inhibitors.
    Liu R; Liu L; Liu T; Yang X; Wan Y; Fang H
    Bioorg Med Chem; 2018 Sep; 26(17):4907-4915. PubMed ID: 30170927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.
    Niu Q; Deng H; Zhang Z; Xu Q; Luan S; Huang M; Liu D; Zhao L
    Bioorg Med Chem Lett; 2021 Sep; 47():128215. PubMed ID: 34153472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, stereochemical determination, molecular docking study, in silico pre-ADMET prediction and anti-proliferative activities of indole-pyrimidine derivatives as Mcl-1 inhibitors.
    Lamie PF; Philoppes JN
    Bioorg Chem; 2021 Nov; 116():105335. PubMed ID: 34509795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and structure-activity relationship studies of N-substituted indole derivatives as novel Mcl-1 inhibitors.
    Luan S; Ge Q; Chen Y; Dai M; Yang J; Li K; Liu D; Zhao L
    Bioorg Med Chem Lett; 2017 May; 27(9):1943-1948. PubMed ID: 28343875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and preliminary bioactivity studies of 2-thioxo-4-thiazolidinone derivatives as Bcl-2 inhibitors.
    Wan Y; Wu S; Xiao G; Liu T; Hou X; Chen C; Guan P; Yang X; Fang H
    Bioorg Med Chem; 2015 May; 23(9):1994-2003. PubMed ID: 25818766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors.
    Fu H; Hou X; Wang L; Dun Y; Yang X; Fang H
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5265-9. PubMed ID: 26421995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and development of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as Bcl-2/Mcl-1 inhibitors.
    Liu R; Liu L; Yang X; Fang H
    Bioorg Chem; 2019 Jul; 88():102938. PubMed ID: 31028992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
    Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
    ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.
    Li R; Cheng C; Balasis ME; Liu Y; Garner TP; Daniel KG; Li J; Qin Y; Gavathiotis E; Sebti SM
    Eur J Med Chem; 2015 Jan; 90():315-331. PubMed ID: 25437618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of Potent and Selective Tricyclic Indole Diazepinone Myeloid Cell Leukemia-1 Inhibitors Using Structure-Based Design.
    Shaw S; Bian Z; Zhao B; Tarr JC; Veerasamy N; Jeon KO; Belmar J; Arnold AL; Fogarty SA; Perry E; Sensintaffar JL; Camper DV; Rossanese OW; Lee T; Olejniczak ET; Fesik SW
    J Med Chem; 2018 Mar; 61(6):2410-2421. PubMed ID: 29323899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and structure-activity relationship studies of novel Bcl-2/Mcl-1 dual inhibitors with indole scaffold.
    Zhang Z; Hou L; Bai L; Pei J; Zhao S; Luan S; Liu D; Huang M; Zhao L
    Bioorg Chem; 2022 Aug; 125():105845. PubMed ID: 35512494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design, synthesis, and evaluation of Bcl-2/Mcl-1 dual inhibitors.
    Zhu J; Wang Z; Guo Z; Zhang X; Song T; Guo Y; Ji T; Zhang Z
    Arch Pharm (Weinheim); 2020 May; 353(5):e2000005. PubMed ID: 32175625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors.
    Wan Y; Wang J; Sun F; Chen M; Hou X; Fang H
    Bioorg Med Chem; 2015 Dec; 23(24):7685-93. PubMed ID: 26620718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the difference between BH3 groove of Mcl-1 and Bcl-2 protein: Implications for dual inhibitors design.
    Zhang Z; Yang H; Wu G; Li Z; Song T; Li XQ
    Eur J Med Chem; 2011 Sep; 46(9):3909-16. PubMed ID: 21684048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
    Leverson JD; Zhang H; Chen J; Tahir SK; Phillips DC; Xue J; Nimmer P; Jin S; Smith M; Xiao Y; Kovar P; Tanaka A; Bruncko M; Sheppard GS; Wang L; Gierke S; Kategaya L; Anderson DJ; Wong C; Eastham-Anderson J; Ludlam MJ; Sampath D; Fairbrother WJ; Wertz I; Rosenberg SH; Tse C; Elmore SW; Souers AJ
    Cell Death Dis; 2015 Jan; 6(1):e1590. PubMed ID: 25590800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.
    Tanaka Y; Aikawa K; Nishida G; Homma M; Sogabe S; Igaki S; Hayano Y; Sameshima T; Miyahisa I; Kawamoto T; Tawada M; Imai Y; Inazuka M; Cho N; Imaeda Y; Ishikawa T
    J Med Chem; 2013 Dec; 56(23):9635-45. PubMed ID: 24215352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2/Mcl-1 dual inhibitors.
    Chen C; Nie Y; Xu G; Yang X; Fang H; Hou X
    Bioorg Med Chem; 2019 Jul; 27(13):2771-2783. PubMed ID: 31079964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.